title: Rosiglitazone and cardiovascular outcomes: is there a clear answer?
authors.forename: Hertzel C
authors.initials: HC
authors.lastname: Gerstein
mesh_terms: D017130:Angioplasty; D003324:Coronary Artery Disease / Q000453:epidemiology* / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D045162:Thiazolidinediones; D000077154:Rosiglitazone
keywords: Editorials; clinical trial; diabetes mellitus; outcome assessment